TT Capital Management LLC Invests $3.24 Million in iShares Biotechnology ETF $IBB

TT Capital Management LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 26,350 shares of the financial services provider’s stock, valued at approximately $3,235,000. iShares Biotechnology ETF comprises about 1.1% of TT Capital Management LLC’s investment portfolio, making the stock its 25th biggest holding. TT Capital Management LLC owned about 0.06% of iShares Biotechnology ETF at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $25,000. Berkshire Money Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the second quarter worth approximately $28,000. Financial Gravity Companies Inc. bought a new position in iShares Biotechnology ETF in the 2nd quarter worth approximately $29,000. Harbor Asset Planning Inc. acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at approximately $31,000. Finally, Trust Co. of Toledo NA OH acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at approximately $32,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.5%

Shares of IBB stock opened at $169.42 on Friday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $174.40. The stock has a fifty day moving average of $161.58 and a two-hundred day moving average of $143.75.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a $0.0828 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.